Moreover, a recently study revealed that dampening IL6/STAT3 activity alleviated the I148M-mediated susceptibility to NAFLD, while boosting it in wild-type liver cultures enhanced the development of NAFLD (83). This evidence concerns the gene STAT3 and metabolic dysfunction-associated steatotic liver disease.